Last updated: 6 August 2021 at 5:03pm EST

Lisa Khorey Net Worth




The estimated Net Worth of Lisa Khorey is at least $7.33 million dollars as of 5 August 2021. Ms. Khorey owns over 50,000 units of Veradigm Inc stock worth over $1,644,786 and over the last 8 years she sold MDRX stock worth over $2,553,900. In addition, she makes $3,135,660 as Executive Vice President et Chief Client Delivery Officer at Veradigm Inc.

Ms. Khorey MDRX stock SEC Form 4 insiders trading

Lisa has made over 6 trades of the Veradigm Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 50,000 units of MDRX stock worth $857,000 on 5 August 2021.

The largest trade she's ever made was selling 50,000 units of Veradigm Inc stock on 5 August 2021 worth over $857,000. On average, Lisa trades about 8,333 units every 20 days since 2016. As of 5 August 2021 she still owns at least 166,308 units of Veradigm Inc stock.

You can see the complete history of Ms. Khorey stock trades at the bottom of the page.





Lisa Khorey biography

Lisa Khorey serves as Executive Vice President, Chief Client Delivery Officer of the Company. She has served as our Executive Vice President, Chief Client Delivery Officer since November 2016. Prior to joining Allscripts, Ms. Khorey was the executive director of Ernst & Young’s National Provider Practice, specializing in analytics. Previously, Ms. Khorey held a variety of technical and executive leadership roles at University of Pittsburgh Medical Center.

What is the salary of Lisa Khorey?

As the Executive Vice President et Chief Client Delivery Officer of Veradigm Inc, the total compensation of Lisa Khorey at Veradigm Inc is $3,135,660. There are 2 executives at Veradigm Inc getting paid more, with Paul Black having the highest compensation of $7,508,610.



How old is Lisa Khorey?

Lisa Khorey is 53, she's been the Executive Vice President et Chief Client Delivery Officer of Veradigm Inc since 2016. There are 13 older and 4 younger executives at Veradigm Inc. The oldest executive at Veradigm Inc is David Stevens, 67, who is the Independent Director.

Insiders trading at Veradigm Inc

Over the last 21 years, insiders at Veradigm Inc have traded over $224,103,456 worth of Veradigm Inc stock and bought 10,933,033 units worth $72,033,281 . The most active insiders traders include Capital Management Llcstone..., Yancey L. Spruill et Michael Kluger. On average, Veradigm Inc executives and independent directors trade stock every 28 days with the average trade being worth of $1,028,807. The most recent stock trade was executed by Capital Management Llcstone... on 28 February 2024, trading 10,222,875 units of MDRX stock currently worth $66,039,773.



What does Veradigm Inc do?

allscripts (nasdaq: mdrx) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. our innovative solutions connect people, places and data across an open, connected community of health™. connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. to learn more, visit www.allscripts.com, twitter, youtube and blog.allscripts.com.



What does Veradigm Inc's logo look like?

Veradigm Inc logo

Complete history of Ms. Khorey stock trades at Veradigm Inc

Date
#
Société
Initié
Trans.
Transaction
Actions Prix par action Prix ​​total Actions après Source
5 Aug 2021 Lisa Khorey
Chief Client Delivery Officer
Vente 50,000 $17.14 $857,000
5 Aug 2021
166,308
15 Jun 2021 Lisa Khorey
Chief Client Delivery Officer
Vente 50,000 $17.54 $877,000
15 Jun 2021
216,308
18 Feb 2021 Lisa Khorey
Chief Client Delivery Officer
Vente 15,000 $16.75 $251,250
18 Feb 2021
236,626
18 Nov 2020 Lisa Khorey
Chief Client Delivery Officer
Vente 15,000 $12.75 $191,250
18 Nov 2020
251,626
14 Oct 2020 Lisa Khorey
Chief Client Delivery Officer
Vente 15,000 $11.04 $165,600
14 Oct 2020
270,889
5 Jun 2020 Lisa Khorey
Chief Client Delivery Officer
Vente 30,000 $7.06 $211,800
5 Jun 2020
285,889


Veradigm Inc executives and stock owners

Veradigm Inc executives and other stock owners filed with the SEC include: